These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36122816)

  • 1. Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.
    Sami F; Acharya P; Noonan G; Maurides S; Al-Masry AA; Bajwa S; Parimi N; Boda I; Tran C; Goyal A; Mastoris I; Dalia T; Sauer A; Bakel AV; Shah Z
    J Card Fail; 2022 Dec; 28(12):1683-1691. PubMed ID: 36122816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone.
    Eaton RE; Kissling KT; Haas GJ; McLaughlin EM; Pickworth KK
    Am J Cardiol; 2022 Dec; 184():80-89. PubMed ID: 36167736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era.
    Mody BP; Khan MH; Zaid S; Ahn C; Lloji A; Aronow WS; Gupta CA; Levine A; Gass AL; Cooper HA; Lanier GM
    Am J Ther; 2020 Oct; 28(6):e621-e630. PubMed ID: 33021537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
    King JB; Shah RU; Sainski-Nguyen A; Biskupiak J; Munger MA; Bress AP
    Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
    Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
    Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
    Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
    Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
    Kelly J; Cheng J; Malloy R; Lupi K
    J Cardiovasc Pharmacol; 2020 May; 75(5):455-459. PubMed ID: 32091426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure.
    Hashim T; Sanam K; Revilla-Martinez M; Morgan CJ; Tallaj JA; Pamboukian SV; Loyaga-Rendon RY; George JF; Acharya D
    Circ Heart Fail; 2015 Sep; 8(5):880-6. PubMed ID: 26179184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
    Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
    Br J Anaesth; 2006 Dec; 97(6):799-807. PubMed ID: 17035336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality.
    Nielsen DV; Torp-Pedersen C; Skals RK; Gerds TA; Karaliunaite Z; Jakobsen CJ
    Crit Care; 2018 Feb; 22(1):51. PubMed ID: 29482650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
    Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
    Rodenas-Alesina E; Luis Scolari F; Wang VN; Brahmbhatt DH; Mihajlovic V; Fung NL; Otsuki M; Billia F; Overgaard CB; Luk A
    ESC Heart Fail; 2023 Aug; 10(4):2577-2587. PubMed ID: 37322827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inotropic therapy in heart failure: general aspects and clinical results].
    Manito N; Kaplinsky EJ; Pujol R
    Med Clin (Barc); 2004 Feb; 122(7):269-74. PubMed ID: 15012878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
    Lowes BD; Tsvetkova T; Eichhorn EJ; Gilbert EM; Bristow MR
    Int J Cardiol; 2001 Dec; 81(2-3):141-9. PubMed ID: 11744130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotating inotrope therapy in a pediatric population with decompensated heart failure.
    Ryerson LM; Alexander PM; Butt WW; Shann FA; Penny DJ; Shekerdemian LS
    Pediatr Crit Care Med; 2011 Jan; 12(1):57-60. PubMed ID: 20453705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.